• $2.3M
    Market Cap
  • -92.60%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
01/31/2024
01/31/2023
01/31/2022
01/31/2021
Income Statement
Total Operating Revenue
0
N/A
0
-100.00%
5.6M
+2,161.56%
248,200
N/A
Cost of Revenue
0
-100.00%
3.3M
-5.99%
3.5M
+2,506.76%
136,000
N/A
Gross Profit
0
+100.00%
-3.3M
-261.17%
2.1M
+1,743.14%
112,200
N/A
Sales and Marketing Expense
1.1M
+32.40%
844,836
+43.95%
586,894
+9.17%
537,582
N/A
Research and Development Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Depreciation and Amortization Expense
15,062
0.00%
15,062
+80.15%
8,361
N/A
0
N/A
Total Operating Expenses
0
-100.00%
3.3M
-5.99%
3.5M
+2,506.76%
136,000
N/A
Operating Profit
-1.1M
-73.23%
-4.2M
+182.08%
-1.5M
+248.18%
-425,382
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
0
-100.00%
8,059
N/A
N/A
N/A
0
N/A
Income before Taxes
-1.1M
-73.17%
-4.2M
+181.53%
-1.5M
+248.18%
-425,382
N/A
Income Taxes
0
+100.00%
-5,381
-102.48%
217,104
N/A
0
N/A
Extraordinary Items
10,449
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-1.1M
-73.14%
-4.2M
+229.46%
-1.3M
+197.15%
-425,382
N/A
Net Income from Continuing Operations Applicable to Common
-1.1M
-73.17%
-4.2M
+229.89%
-1.3M
N/A
0
N/A
Basic EPS and Net Income
N/A
N/A
N/A
N/A
N/A
N/A
0.00
N/A
Diluted EPS and Net Income
-0.01
-50.00%
-0.02
N/A
N/A
N/A
0.00
N/A
Basic Weighted Average Shares
207.0M
+0.25%
206.5M
+0.26%
206.0M
+126.13%
91.1M
N/A
Diluted Weighted Average Shares
207.0M
+0.25%
206.5M
+0.26%
206.0M
+126.13%
91.1M
N/A
Balance Sheet
Cash and Cash Equivalents
13
-99.96%
29,656
-72.34%
107,212
+136.16%
45,398
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
13
-99.96%
29,656
-72.34%
107,212
+136.16%
45,398
N/A
Total Current Assets
23,627
-94.59%
437,078
-85.73%
3.1M
+1,516.63%
189,398
N/A
Accumulated Depreciation
38,485
+64.30%
23,423
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
24,063
-51.46%
49,574
-23.30%
64,636
N/A
N/A
N/A
Total Long-Term Assets
113,715
-65.42%
328,870
-39.35%
542,205
N/A
N/A
N/A
Total Assets
137,342
-82.07%
765,948
-78.75%
3.6M
+1,802.91%
189,398
N/A
Income Taxes Payable
218,714
0.00%
218,714
+0.74%
217,104
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
3.5M
+13.63%
3.1M
+97.14%
1.6M
+1,573.35%
93,034
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
0
-100.00%
93,334
-80.13%
469,753
N/A
N/A
N/A
Total Liabilities
3.5M
+10.28%
3.2M
+56.05%
2.0M
+2,003.00%
96,364
N/A
Retained Earnings
-4.5M
+33.02%
-3.4M
+314.83%
-816,724
+82.60%
-447,278
N/A
Total Stockholders Equity
-3.4M
+39.80%
-2.4M
-251.91%
1.6M
+1,537.06%
96,364
N/A
Total Shares Outstanding
207.0M
0.00%
207.0M
-1.26%
209.7M
+1,094,782.66%
19,150
N/A
Cash Flow
Cash from Operating Activities
-34,920
-54.97%
-77,556
-191.45%
84,811
+301.31%
-42,130
N/A
Capital Expenditures
N/A
N/A
0
-100.00%
72,997
N/A
N/A
N/A
Cash from Investing Activities
N/A
N/A
0
-100.00%
72,997
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
5,277
N/A
0
-100.00%
50,000
-42.88%
87,528
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
36.84%
-18.50%
45.21%
N/A
Operating Margin
N/A
N/A
N/A
N/A
-26.39%
-84.60%
-171.39%
N/A
Return on Assets
-247.66%
+29.95%
-190.59%
+185.99%
-66.64%
-85.16%
-449.19%
N/A
Return on Equity
38.93%
-96.17%
1,017.00%
+773.40%
-151.02%
-84.12%
-951.16%
N/A
Revenue Growth
N/A
N/A
-100.00%
-104.63%
2,161.56%
+40.42%
1,539.37%
N/A
Current Ratio
0.007
-95.22%
0.14
-92.76%
1.97
-3.39%
2.04
N/A
Cash Ratio
0.00
-100.00%
0.010
-85.92%
0.07
-85.88%
0.49
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow